Pricing

Log inSign up

VistaGen Therapeutics

4 followers

‌

VistaGen Therapeutics (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company developing new generation medicines for multiple CNS diseases and disorders with high unmet need.

Industries

Education, Pharmaceutical

Headquarters

South San Francisco, United States

Employees

11-50

Links

Org chart

Shawn K. Singh
CEO & Director

Shawn K. Singh

Collapse
Reid Adler
Chief Legal Officer
Cindy Anderson
CFO
Mark J. Ginski
SVP, Head of CMC
Allen Cato III
SVP, Development Operations
Trisha Fitzmaurice
SVP, Human Resources
Joshua Prince
VP, Strategic Insights & Analytics
Louis Monti
VP, Translational Medicine
Ross A. Baker
VP, Global Medical Affairs
Mark Flather
VP, Investor Relations
Mark A. McPartland
VP, Corporate Development
Ester Salmán
VP, Clinical Research

Board & advisors

Jon S. Saxe
Chairman
Ann M. Cunningham
Member, Board Of Directors
Jerry Gin
Director
BU
Brian J. Underdown
Director
Joanne Curley
Director
Mary L. Rotunno
Director
MF
Maurizio Fava
Chairman
GK
Gordon Keller
Advisor
TL
Thomas Laughren
Advisor
ML
Michael Liebowitz
Advisor
SM
Sanjay Mathew
Advisor
GS
Gerard Sanacora
Advisor
MW
Mark Wallace
Advisor

Teams

+2

Leadership Team

5 members

+3

Clinical and Medical Team

6 members

Legal and Compliance

3 members

HS
KC

Project Management

3 members

Regulatory and Quality Affairs

2 members

Offices

Similar companies

Mirum Pharmaceuticals

3 followers

UNC Charlotte

6 followers

Lenz Therapeutics

3 followers

Madrigal Pharmaceuticals

2 followers

Kyverna Therapeutics

7 followers

Thurgood Marshall College Fund

1 follower

AVEO Oncology

2 followers

A-Alpha Bio

1 follower

Lisata Therapeutics

1 follower

Bristol-Myers Squibb

208 followers

Walgreens Boots Alliance

112 followers

Explore companies